[Federal Register Volume 81, Number 62 (Thursday, March 31, 2016)]
[Notices]
[Pages 18631-18632]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07225]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30 Day-16-1074]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) has submitted 
the following information collection request to the Office of 
Management and Budget (OMB) for review and approval in accordance with 
the Paperwork Reduction Act of 1995. The notice for the proposed 
information collection is published to obtain comments from the public 
and affected agencies.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address any of the following: (a) 
Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility; (b) Evaluate the 
accuracy of the agencies estimate of the burden of the proposed 
collection of information, including the validity of the methodology 
and assumptions used; (c) Enhance the quality, utility, and clarity of 
the information to be collected; (d) Minimize the burden of the 
collection of information on those who are to respond, including 
through the use of appropriate automated, electronic, mechanical, or 
other technological collection techniques or other forms of information 
technology, e.g., permitting electronic submission of responses; and 
(e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Written comments and/or 
suggestions regarding the items contained in this notice should be 
directed to the Attention: CDC Desk Officer, Office of Management and 
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written 
comments should be received within 30 days of this notice.

Proposed Project

Colorectal Cancer Control Program (CRCCP) Monitoring Activities

--Reinstatement with Change (OMB No. 0920-1074, exp. 12/31/2015)
--National Center for Chronic Disease Prevention and Health Promotion 
(NCCDPHP), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    CDC is requesting a reinstatement with change of the information 
collect project assigned OMB Control Number 0920-1074, formerly 
entitled ``Annual Survey of Colorectal Cancer Control Activities 
Conducted by States and Tribal Organizations.'' In the previous OMB 
approval period, information collection consisted of an annual grantee 
survey. In the next OMB approval period, information collection will 
consist of a redesigned survey and a new clinic-level information 
collection. The number of respondents will increase and the total 
estimated annualized burden will increase.
    Among cancers that affect both men and women, colorectal cancer 
(CRC) is the second leading cause of death from cancer in the United 
States. CRC screening has been shown to reduce incidence of and death 
from the disease. Screening for CRC can detect disease early when 
treatment is more effective and prevent cancer by finding and removing 
precancerous polyps. Of individuals diagnosed with early stage CRC, 
more than 90% live five or more years. Despite strong evidence 
supporting screening, only 65% of adults currently report being up-to-
date with CRC screening as recommended by the U.S. Preventive Services 
Task Force, with more than 22 million age-eligible adults estimated to 
be untested. To reduce CRC morbidity, mortality, and associated costs, 
use of CRC screening tests must be increased among age-eligible adults 
with the lowest CRC screening rates.
    CDC's Colorectal Cancer Control Program (CRCCP) currently provides 
funding to 31 grantees under ``Organized Approaches to Increase

[[Page 18632]]

Colorectal Cancer Screening'' (CDC-RFA-DP15-1502). CRCCP grantees 
include state governments or bona-fide agents, universities, and tribal 
organizations. The purpose of the new cooperative agreement program is 
to increase CRC screening rates among an applicant defined target 
population of persons 50-75 years of age within a partner health system 
serving a defined geographical area or disparate population.
    The CRCCP was significantly redesigned in 2015 and has two 
components. Under Component 1, all 31 CRCCP grantees receive funding to 
support partnerships with health systems to implement up to four 
priority evidence-based interventions (EBIs) described in the Guide to 
Community Preventive Services, as well as other supporting strategies. 
Grantees must implement at least two EBIs in each partnering health 
system. Under Component 2, 6 of the 31 CRCCP grantees will provide 
direct screening and follow-up clinical services for a limited number 
of individuals aged 50-64 in the program's priority population who are 
asymptomatic, at average risk for CRC, have inadequate or no health 
insurance for CRC screening, and are low income.
    Based on the redesigned CRCCP, the information collection plan has 
also been redesigned to address the two program components. The new 
cooperative agreement program (CDC-RFA-DP15-1502) requires that CDC 
monitor and evaluate the CRCCP and individual grantee performance using 
both process and outcome evaluation. Two forms are proposed. First, the 
CRCCP grantee survey was redesigned to align with new CRCCP goals. The 
grantee survey will be submitted to CDC annually. Second, CDC proposes 
to collect clinic-level information to assess changes in CDC's primary 
outcome of interest, i.e., CRC screening rates within partner health 
systems. Each grantee will complete a clinic-level collection template 
once per year. All information will be reported to CDC electronically.
    The information collection will enable CDC to gauge progress in 
meeting CRCCP program goals and to monitor implementation activities, 
evaluate outcomes, and identify grantee technical assistance needs. In 
addition, findings will inform program improvement and help identify 
successful activities that need to be maintained, replicated, or 
expanded.
    OMB approval is requested for three years. Participation is 
required for CRCCP awardees. In the pilot test for the CRCCP annual 
grantee survey, the average time to complete the instrument was 
approximately 45 minutes. In the pilot test for the CRCCP clinic-level 
information collection, the average time to complete the instrument was 
approximately 30 minutes. CDC estimates an average of 12 responses per 
grantee annually to correspond with the number of health system 
partners. The total estimated annualized burden hours are 209. There 
are no costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondent                    Form name            Number of     responses per   per response
                                                                    respondents     respondent        (in hr)
----------------------------------------------------------------------------------------------------------------
CRCCP Grantees........................  CRCCP Annual Grantee                  31               1           45/60
                                         Survey.
                                        CRCCP Clinic-level                    31              12           30/60
                                         Information Collection
                                         Template.
----------------------------------------------------------------------------------------------------------------


Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific 
Integrity, Office of the Associate Director for Science, Office of the 
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-07225 Filed 3-30-16; 8:45 am]
BILLING CODE 4163-18-P